Identification of three miRNAs signature as a prognostic biomarker in breast cancer using bioinformatics analysis.

Abstract

BackgroundAccumulating evidences indicated that some miRNAs are dysregulated in breast cancer and involved in cell growth, migration and invasion, differentiation, cell cycle arrest, apoptosis, and autophagy. Our study aims to identify a novel set of biomarkers for predicting the prognosis of breast cancer patients.MethodsWe downloaded clinical information and raw sequencing data from The Cancer Genome Atlas (TCGA) database. We selected samples with miRNA sequencing data and relevant clinical prognostic data for subsequent analysis. The association between miRNA and prognosis function was analyzed by Cox regression analysis. The potential biofunctions of target miRNAs were investigated through bioinformatic analysis.ResultsWe identified 84 differentially expressed miRNAs (DEmiRNAs), among them, 17 were downregulated and 67 were upregulated. We used Kaplan-Meier survival analysis to evaluate the prognostic value of three miRNAs (mir-105-1, mir-301b and mir-1258). We also found that the three-miRNA signature is independent prognostic factors for breast cancer by using Cox regression analysis. It might be participated in different signaling pathways associated with cancer by using functional enrichment analysis, including adherens junction, autophagy, and TGF-beta signaling pathway, ErbB signaling pathway, FoxO signaling pathway.ConclusionsTaken together, three-miRNA signature might be used as a potential predicting prognostic biomarker in breast cancer.